Description
Springer Pulmonary Manifestations of Rheumatic Disease A Comprehensive Guide 1st Editon 2016 Softbound by Paul F. Dellaripa, Aryeh Fischer, Kevin R. Flaherty
The spectrum of systemic rheumatologic disease (often termed connective tissue disease) is characterized by autoimmune-mediated organ dysfunction, and the lungs are a frequent target. There are numerous pulmonary manifestations associated with connective tissue diseases, and all patients with rheumatologic disease are at risk of developing associated lung disease. Pulmonary Manifestations of Rheumatic Disease covers the comprehensive management of rheumatologic lung disease, which requires a multi-disciplinary approach and is optimized by active engagement by rheumatologists working closely with pulmonologists and other specialists. The book offers a practical reference using a case-based approach for practicing clinicians in the ongoing assessment and understanding of rheumatologic lung disease, and presents the science and pathophysiology underlying rheumatologic lung diseases. The first text of its kind specifically dedicated to describe diverse, commonplace, and challenging aspects of rheumatologic lung diseases, Pulmonary Manifestations of Rheumatic Disease serves as an invaluable tool for the practicing clinician. 1: The Lung in Rheumatic Diseases.- 2: Evaluation of Lung Disease in Patients with Connective Tissue Disease.- 3: Rheumatoid Arthritis.- 4: Interstitial Lung Disease in Systemic Sclerosis.- 5: Inflammatory Myopathy/Anti-Synthetase Syndrome.- 6: Pulmonary Manifestations of Systemic Lupus Erythematosus (SLE).- 7: Pulmonary Manifestations in Mixed Connective Tissue Disease.- 8: Pulmonary Manifestations of Primary Sjögren's Syndrome.- 9: Pulmonary Manifestations of Sarcoidosis.- 10: Pulmonary Manifestations of Vasculitis.- 11: Pulmonary Hypertension Associated with Connective Tissue Disease.- 12: Respiratory Infections in the Rheumatic Disease Patient.- 13: Lung Transplantation for Connective Tissue Disease-Associated Lung Disease.- 14: Current and Emerging Treatment Options in Interstitial Lung Disease.